DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 5 USDMF

5 API Suppliers
5 USDMF

FINISHED DOSAGE FORMULATIONS

195 FDF Dossiers, 17 FDA Orange Book, 118 Europe, 5 Canada, 55 South Africa

195 FDF Dossiers
17 FDA Orange Book
118 Europe
5 Canada
55 South Africa

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3.5-150mCi/VIAL, CAPSULE;ORAL - 0.8-100mCi, CAPSULE;ORAL - 0.009-0.1mCi, SOLUTION;ORAL - 250-1000mCi

drugProductComposition
SOLUTION;ORAL - 3.5-150mCi/VIAL
CAPSULE;ORAL - 0.8-100mCi
CAPSULE;ORAL - 0.009-0.1mCi
SOLUTION;ORAL - 250-1000mCi

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

110 Finished Drug Prices

globalSalesInformation
110 Finished Drug Prices

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

195

FDF Dossiers

FDA Orange Book

118

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Sodium iodide i-131, Sodium iodide-131, 7790-26-3, Theriodide, Tracervial, Iodotope

Molecular Formula

INa

Molecular Weight

153.895896 g/mol

InChI Key

FVAUCKIRQBBSSJ-LAIFMVDKSA-M

FDA UNII

29VCO8ACHH

Sodium Iodide I-131 is a radiopharmaceutical containing the beta- and gamma-emitting radioisotope I-131. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing the imaging of the thyroid.

1 2D Structure

Sodium Iodide-131

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

sodium;iodine-131(1-)

2.1.2 InChI

InChI=1S/HI.Na/h1H;/q;+1/p-1/i1+4;

2.1.3 InChI Key

FVAUCKIRQBBSSJ-LAIFMVDKSA-M

2.1.4 Canonical SMILES

[Na+].[I-]

2.1.5 Isomeric SMILES

[Na+].[131I-]

2.2 Other Identifiers

2.2.1 UNII

29VCO8ACHH

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Sodium Iodide I-131

2. Sodium Iodide-131

3. 7790-26-3

4. Theriodide

5. Tracervial

6. Iodotope

7. Oriodide

8. Radiocaps

9. Sodium Iodide (131i)

10. Sodium Iodide, I-131

11. Sodium;iodine-131(1-)

12. Theriodide-131

13. Tracervial-131

14. Radiocaps-131

15. Sodium Iodide I131

16. Iodine (131i) Sodium

17. 29vco8achh

18. Sodium Iodide (131 I)

19. Sodium Iodide (na131i)

20. Sodium Iodide (131i) [inn]

21. Hicon

22. Natrii Radioiodidum

23. Iodotope (tn)

24. Iodotope Therapeutic

25. Hicon (tn)

26. Iodotope I-131

27. Sodium Iodide-131i

28. Sodium Iodide,i-131

29. Unii-29vco8achh

30. (131-i)sodium Iodide

31. Ioduro Sodico (131i)

32. Natrii Iodidum (131i)

33. Sodium Iodide, Radioactive

34. Ioduro Sodico (131 I)

35. Sodium Iodide (i-131)

36. Natrii Iodidum (131 I)

37. Natrii Jodidum (131 I)

38. Iodure (131i) De Sodium

39. Sodium Iodide I 131, Kit

40. Iodure (131 I) De Sodium

41. Natrium Radio-iodatum (131i)

42. Chembl1201084

43. Natrium Radio-iodatum (131 I)

44. Sodium Iodide (131i) Capsules

45. Sodium Iodide (na(sup 131)i)

46. Dtxsid701014487

47. Sodium Iodide I 131 [mi]

48. Sodium Iodide I 131 (jp17/usp)

49. Sodium Iodide I 131 [hsdb]

50. Sodium Iodide I 131 [usan]

51. Sodium Iodide ((sup 131)i) Capsules

52. Sodium Iodide,i-131 [vandf]

53. Natrii Iodidum (131 I) [inn-latin]

54. Ioduro Sodico (131 I) [inn-spanish]

55. Sodium Iodide I 131 [usan:usp:inn]

56. Iodure (131 I) De Sodium [inn-french]

57. Sodium Iodide (131 I) [who-dd]

58. Sodium Iodide I-131 [orange Book]

59. Sodium Iodide I 131 [usp Impurity]

60. D02259

61. Q22075909

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	INa
Molecular Weight	153.895896 g/mol
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	1
Rotatable Bond Count	0
Exact Mass	153.895896 g/mol
Monoisotopic Mass	153.895896 g/mol
Topological Polar Surface Area	0 Å²
Heavy Atom Count	2
Formal Charge	0
Complexity	2
Isotope Atom Count	1
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 4
Drug Name	Sodium iodide i 131
Active Ingredient	Sodium iodide i-131
Dosage Form	Capsule; Solution
Route	Oral
Strength	3.5-150mci/vial; 0.8-100mci
Market Status	Prescription
Company	Mallinckrodt

2 of 4
Drug Name	Sodium iodide i-131
Active Ingredient	Sodium iodide i-131
Dosage Form	Capsule
Route	Oral
Strength	9-100mci
Market Status	Prescription
Company	Jubilant Draximage

3 of 4
Drug Name	Sodium iodide i 131
Active Ingredient	Sodium iodide i-131
Dosage Form	Capsule; Solution
Route	Oral
Strength	3.5-150mci/vial; 0.8-100mci
Market Status	Prescription
Company	Mallinckrodt

4 of 4
Drug Name	Sodium iodide i-131
Active Ingredient	Sodium iodide i-131
Dosage Form	Capsule
Route	Oral
Strength	9-100mci
Market Status	Prescription
Company	Jubilant Draximage

5 Pharmacology and Biochemistry

5.1 FDA Pharmacological Classification

5.1.1 Pharmacological Classes

Radiopharmaceutical Activity [MoA]; Radioactive Therapeutic Agent [EPC]

5.2 ATC Code

V - Various

V09 - Diagnostic radiopharmaceuticals

V09F - Thyroid

V09FX - Various thyroid diagnostic radiopharmaceuticals

V09FX03 - Sodium iodide (131I)

V - Various

V10 - Therapeutic radiopharmaceuticals

V10X - Other therapeutic radiopharmaceuticals

V10XA - Iodine (131i) compounds

V10XA01 - Sodium iodide (131I)

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION;ORAL - 3.5-150mCi/VIAL

USFDA APPLICATION NUMBER - 16515

DOSAGE - CAPSULE;ORAL - 0.8-100mCi

USFDA APPLICATION NUMBER - 16517

DOSAGE - CAPSULE;ORAL - 0.009-0.1mCi

USFDA APPLICATION NUMBER - 21305

DOSAGE - SOLUTION;ORAL - 250-1000mCi

USFDA APPLICATION NUMBER - 21305

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Sodium Iodide-131 manufacturers, exporters & distributors on PharmaCompass

Sodium Iodide-131

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers

5 USDMF

FINISHED DOSAGE FORMULATIONS

195 FDF Dossiers

17 FDA Orange Book

118 Europe

5 Canada

55 South Africa

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3.5-150mCi/VIAL

CAPSULE;ORAL - 0.8-100mCi

CAPSULE;ORAL - 0.009-0.1mCi

SOLUTION;ORAL - 250-1000mCi

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

110 Finished Drug Prices

MARKET PLACE

1 APIs

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?